Patents by Inventor Zeyu CAO

Zeyu CAO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230173006
    Abstract: An application of a traditional Chinese medicine composition to preparation of a medicine for treating or preventing coronavirus infection. The composition is prepared from the following raw material medicines in parts by weight: 1-3 parts of honey-fried herba ephedrae, 1-10 parts of semen armeniacae amarum, 1-6 parts of radix platycodonis, 1-6 parts of radix peucedani, 1-6 parts of bulbus fritillariae thunbergii, 1-6 parts of radix stemonae, 1-3 parts of oroxylum indicum, 1-10 parts of radix glehniae and 1-3 parts of radix glycyrrhizae. The diluent of the traditional Chinese medicine composition can protect Vero cells infected with 2019-nCov virus.
    Type: Application
    Filed: March 10, 2021
    Publication date: June 8, 2023
    Applicant: JIANGSU KANION PHARMACEUTICAL CO., LTD.
    Inventors: Wei XIAO, Xinzhuang ZHANG, Zhipeng KE, Zhenzhen SU, Xiaoqian TAO, Yi DENG, Zeyu CAO, Liang CAO, Zhenzhong WANG, Xiaolian HE, Xuehong DONG, Yanqiu WANG
  • Publication number: 20230173011
    Abstract: Application of a traditional Chinese medicine composition to preparation of a medicine for treating or preventing coronavirus infection. The traditional Chinese medicine composition includes: 2-10 parts of flos lonicerae, 2-10 parts of fructus forsythiae, 2-6 parts of herba menthae, 2-4 parts of herba schizonepetae, 2-5 parts of fermented soybean, 2-6 parts of fried arctii fructus, 2-6 parts of radix platycodonis, 2-4 parts of herba lophatheri and 2-5 parts of radix glycyrrhizae. The traditional Chinese medicine composition has a good effect of treating or preventing coronavirus-related diseases.
    Type: Application
    Filed: March 11, 2021
    Publication date: June 8, 2023
    Applicant: JIANGSU KANION PHARMACEUTICAL CO., LTD.
    Inventors: Wei XIAO, Zhenzhen SU, Xiaoqian TAO, Zhipeng KE, Xinzhuang ZHANG, Zeyu CAO, Yi DENG, Liang CAO, Zhenzhong WANG, Xiaolian HE, Xuehong DONG, Yanqiu WANG
  • Publication number: 20230158095
    Abstract: Application of a traditional Chinese medicine composition to preparation of a medicine for treating or preventing coronavirus infection. The traditional Chinese medicine composition includes: 5-30 parts of herba houttuyniae, 5-30 parts of flos lonicerae, 5-20 parts of radix paeoniae rubra, 3-15 parts of folium artemisiae argyi and 3-15 parts of herba menthae. The traditional Chinese medicine composition has a good effect of treating or preventing coronavirus-related diseases.
    Type: Application
    Filed: March 11, 2021
    Publication date: May 25, 2023
    Applicant: JIANGSU KANION PHARMACEUTICAL CO., LTD.
    Inventors: Wei XIAO, Xiaoqian TAO, Xinzhuang ZHANG, Zhenzhen SU, Zhipeng KE, Zeyu CAO, Liang CAO, Xiaolian HE, Xuehong DONG, Yanqiu WANG
  • Publication number: 20230080878
    Abstract: An application of a traditional Chinese medicine composition in preparing a medicine for treating or preventing coronavirus infection. The traditional Chinese medicine composition is characterized by being prepared from the following raw materials in parts by weight: 5-15 parts of Cornu saigae tataricae or 50-150 parts of goral horns, 10-60 parts of Bulbus Fritillariae Ussuriensis, 15-60 parts of Radix et Rhizoma Rhei, 7-30 parts of Radix scutellariae, 7-30 parts of Lapis Chloriti, 10-50 parts of gypsum fibrosum, 5-20 parts of calculus bovis artifactus, and 15-60 parts of radix glycyrrhizae. The traditional Chinese medicine composition can inhibit 2019-nCoV replication in cells, so that cells infected by 2019-nCoV viruses have no lesion. Therefore, the traditional Chinese medicine composition can treat or prevent coronavirus related diseases.
    Type: Application
    Filed: December 16, 2020
    Publication date: March 16, 2023
    Applicant: JIANGSU KANION PHARMACEUTICAL CO., LTD.
    Inventors: Wei XIAO, Liang CAO, Zhenzhong WANG, Chenfeng ZHANG, Xinzhuang ZHANG, Zeyu CAO
  • Patent number: 11524041
    Abstract: A Ginkgo diterpene lactone composition is provided. The composition has the effect of improving a depressive state. The composition can prolong a tail flick interval time and a swimming interval time of a mouse to different degrees and can also increase the frequency of escaping from electric shock to different degrees. The additional addition of a certain amount of ginkgolide C, ginkgolide J, and ginkgolide L greatly enhances the effect of improving the depressive state. It is further proved through experiments that after the provision of the Ginkgo diterpene lactone composition, indexes, such as SOD, MDA, GSH, and TAC, can be improved to different degrees. For example, after the addition of a certain amount of ginkgolide C, ginkgolide J, and ginkgolide L, the improving effect gets more obvious, the oxidative stress level can be better improved, and the oxidative damage can be relieved.
    Type: Grant
    Filed: November 13, 2018
    Date of Patent: December 13, 2022
    Assignee: JIANGSU KANION PHARMACEUTICAL CO., LTD
    Inventors: Wei Xiao, Enli Zhou, Zeyu Cao, Xiujuan Chang, Xiaodong Kang, Yongxiang Wang, Hanfei Hu, Yun Wu, Zhenzhong Wang, Chenfeng Zhang
  • Publication number: 20210196773
    Abstract: A Ginkgo diterpene lactone composition is provided. The composition has the effect of improving a depressive state. The composition can prolong a tail flick interval time and a swimming interval time of a mouse to different degrees and can also increase the frequency of escaping from electric shock to different degrees. The additional addition of a certain amount of ginkgolide C, ginkgolide J, and ginkgolide L greatly enhances the effect of improving the depressive state. It is further proved through experiments that after the provision of the Ginkgo diterpene lactone composition, indexes, such as SOD, MDA, GSH, and TAC, can be improved to different degrees. For example, after the addition of a certain amount of ginkgolide C, ginkgolide J, and ginkgolide L, the improving effect gets more obvious, the oxidative stress level can be better improved, and the oxidative damage can be relieved.
    Type: Application
    Filed: November 13, 2018
    Publication date: July 1, 2021
    Inventors: Wei XIAO, Enli ZHOU, Zeyu CAO, Xiujuan CHANG, Xiaodong KANG, Yonxiang WANG, Hanfei HU, Yun WU, Zhenzhong WANG, Chenfeng ZHANG